Drug Type Chemical drugs |
Synonyms alpha- Crocin |
Target |
Action inhibitors |
Mechanism Hormone sensitive lipase inhibitors, Lipid peroxidation inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC44H64O24 |
InChIKeySEBIKDIMAPSUBY-RTJKDTQDSA-N |
CAS Registry42553-65-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Serous Chorioretinopathy | Phase 3 | Iran | 01 Jul 2021 | |
Osteoarthritis, Knee | Phase 3 | United States | 20 Jul 2016 | |
Lipid Metabolism Disorders | Phase 3 | - | - | |
Lipid Metabolism Disorders | Phase 3 | - | - | |
Malaria | Phase 3 | - | - | |
Malaria | Phase 3 | - | - | |
Malaria | Phase 3 | - | - | |
Stroke | Phase 3 | - | - | |
Stroke | Phase 3 | - | - | |
Stroke | Phase 3 | - | - |